Lv5
1296 积分 2025-02-28 加入
Tissue-specific thresholds of mutation burden associated with anti-PD-1/L1 therapy benefit and prognosis in microsatellite-stable cancers
1天前
已完结
Predictive Value of PIK3CA Mutations for Response to CDK4/6 Inhibitors in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
1天前
已完结
PI3K mutations detected in liquid biopsy are associated to reduced sensitivity to CDK4/6 inhibitors in metastatic breast cancer patients
1天前
已完结
Datopotamab–deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial
7天前
已完结
Preparation and in vitro/in vivo evaluation of uniform-sized Goserelin-loaded sustained release microspheres
15天前
已完结
Goserelin/PLGA solid dispersion used to prepare long-acting microspheres with reduced initial release and reduced fluctuation of drug serum concentration in vivo
15天前
已完结
Clinical Pharmacokinetics of Depot Leuprorelin
16天前
已完结
Ovarian Function Suppression in Premenopausal Women With Concurrent Endocrine Therapy Use
16天前
已完结
A multicenter phase II trial of nab‐paclitaxel and capecitabine in HER‐2 negative and triple‐ negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?
17天前
已完结
6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)
22天前
已完结
皖公网安备34019202002308
